Q. J. Schief and . Sattentau, Immune focusing and enhanced neutralization induced by HIV-1, 2013.

C. A. Todd, D. A. Ozaki, M. Seaman, J. R. Mascola, and D. C. Montefiori, Optimization and 599 validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against 600 HIV-1, J Immunol Methods, vol.409, pp.131-146, 2014.

D. C. Haynes, G. Montefiori, and . Ferrari, High-throughput quantitative analysis of HIV-1, 2011.

2. S. Barnett, I. K. Srivastava, E. Kan, F. Zhou, A. Goodsell et al., Protection of macaques, pp.614-615, 2008.

S. S. Karim, A. D. Kashuba, L. Werner, and Q. A. Karim, Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women, The Lancet, vol.378, issue.9787, pp.279-281, 2011.
DOI : 10.1016/S0140-6736(11)60878-7

J. Mahmoud, E. Hall, G. Giles, M. Voss, N. Page et al., Antibody 632 responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol 633 gel are augmented by systemic priming or boosting with an adjuvanted formulation, Vaccine, vol.29, issue.634, pp.1421-1430, 2011.

G. D. Mcelrath, F. Tomaras, and . Hladik, HIV-1 specific IgA detected in vaginal secretions 638 of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily 639 directed toward gp120 and gp140 specificities, PLoS One, vol.9, p.640, 2014.

J. M. Lund, Partners PrEP Study Team. 2015. Antiretroviral Pre-Exposure Prophylaxis Does 643

M. A. Nelson, L. J. Jarvis, and . Picker, Effector memory T cell responses are associated with 648 protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge, Nat Med, vol.649, pp.15-293, 2009.

N. L. Rerks-ngarm, J. H. Michael, and . Kim, Immune-correlates analysis of an HIV-1, 2012.